Editing Data Dictionary: National Cancer Registry (RON) (Portugal)

Go back to [[Data Dictionary: Southern Regional Oncology Registry (ROR-Sul) (Portugal)]] page

Source: [https://ron.min-saude.pt/media/2198/ron_comissao_formulario_v2.pdf Click here to learn more].

{| class="wikitable"
|-
! Variables
|-
| Sex
|-
| Date of birth
|-
| Place of residence (at the time of diagnosis)
|-
| District or county
|-
| Date of symptom onset
|-
| Date of first observation
|-
| Date of first consultation
|-
| Date of therapeutic decision consultation (CDT)
|-
| Date of morphological pathology
|-
| ICDO-3 Topography
|-
| ICDO-3 Morphology
|-
| Laterality
|-
| Stage at presentation
|-
| If metastatic: location of metastases
|-
| Degree of differentiation (6th digit of the ICDO-3 code); 1=Grade I, well differentiated; Grade II, moderately differentiated; 3=Grade III, poorly differentiated; 4=Grade IV, undifferentiated; 8=not determined; 9=unknown
|-
| Clinical TNM cTX; cT0-cT4; cNx; cN0-cN3 M0; M1
|-
| Clinical diameter (mm)
|-
| Pathological TNM pTX; pT0-pT4 pNx; pN0-pN3 M0; M1
|-
| Pathological diameter (mm)
|-
| Stage (I-IV)
|-
| Positive/resected lymph nodes (number)
|-
| Ann Arbor I-IV; Unknown
|-
| RAI
|-
| Binet
|-
| FAB
|-
| ISS
|-
| Durie and Salmon
|-
| Hasenclever
|-
| IPI
|-
| FLIPI
|-
| CSS
|-
| Dukes
|-
| Gleason
|-
| Breslow
|-
| Ki67
|-
| Ulceration
|-
| Focality
|-
| B symptoms
|-
| Tumor regression
|-
| Estrogen receptors
|-
| Progesterone receptors
|-
| HER2
|-
| IPOPF, Rua Dr António Bernardino de Almeida | 4200-072 Porto
|-
| Sentinel lymph node Yes/No/Unknown
|-
| Genetic alterations
|-
| BRAF mutation
|-
| KRAS mutation
|-
| EGFR mutation
|-
| ALK rearrangement
|-
| RB1 mutation
|-
| P53 mutation
|-
| IDH1 mutation
|-
| ATRX mutation
|-
| MGMT methylation
|-
| Co-del(1p19q)
|-
| Del(11q)
|-
| Del(13q)
|-
| Del(17p)
|-
| t(11;14)
|-
| t(14;16)
|-
| t(4;14)
|-
| Trisomy 5
|-
| Trisomy 9
|-
| Trisomy 12
|-
| Trisomy 15
|-
| Somatic hypermutation of immunoglobulin heavy chains Present/Absent/Unknown/Not evaluated
|-
| Charlson comorbidity index
|-
| Performance Status (ECOG) 0-4; 5 = unknown
|-
| Anti-tumor activity treatment
|-
| Surveillance Yes/No
|-
| Treatment type Surgery Radiotherapy Cellular therapy Systemic treatment Other treatment
|-
| If systemic treatment: Access regimen (PAP, Conventional, Clinical trial) Regimen/Drug Start date End date Number of cycles administered
|-
| If surgery: Date Procedure Target intervention Surgical radicality
|-
| If radiotherapy: Start date End date Radiotherapy type Technique Irradiated site
|-
| If cellular therapy: Date Type
|-
| If other treatment: Date Type
|-
| Vital status Alive/Dead
|-
| Cause of death Tumor/Other cause/Unknown
|-
| Date of last contact
|}